Ovarian Cancer section

Ovarian Cancer News & Features

Chemotherapy dosages in overweight or obese patients with ovarian cancer

Overweight or obese patients with ovarian cancer are typically given lower per-pound chemotherapy doses to reduce toxic side effects, which could impact their survival chances.

Leisure sitting time associated with increased risk of cancer in women

Leisure sitting time associated with increased risk of cancer in women

Researchers have found that spending more leisure time sitting was associated with an increased risk for developing cancer in women.

Fostamatinib-paclitaxel combination may shrink ovarian cancers

Researchers have found that the experimental drug fostamatinib, combined with the chemotherapy drug paclitaxel, may overcome ovarian cancer cells' resistance to paclitaxel.

Genetic variants key to understanding origins of ovarian cancer

The discovery of three genetic variants associated with mucinous ovarian carcinomas (MOCs) offers the first evidence of genetic susceptibility in this type of ovarian cancer.

Biomarker may boost ovarian cancer response to chemotherapy

Researchers have identified a molecule that may play a central role in chemotherapy resistance in patients with the most common ovarian cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs